So a retinal vein occlusion is when there is an occlusion in the blood vessels of the retina that are particularly the veins, and it causes a lack of blood flow, or a lack of perfusion ...

Retinal Vein Occlusion Market New report uncovers key trends and growth opportunities in the Retinal Vein Occlusion market, focusing on i ...

The dilemma still holds regarding treatment of the very ischemic central retinal vein occlusion subgroup with ME with profound visual loss. Combination therapy of anti-VEGF agents and a steroid ...

Siloton’s handheld OCT system could soon be used for home-based monitoring of retinal disease, and may one day find its way onto future space missions ...

During the 2024 AAO Annual Meeting, presenters discussed various posters and research on retinal vascular health.

Kalaris is a clinical-stage biopharmaceutical company founded by Samsara BioCapital and focused on development of TH103, a ...

KOCHI: 68-year-old Thankamma (name changed) from Ernakulam has been a diabetic patient for 15 years. As she did not manage ...

To date, Vabysmo is approved in more than 100 countries for DME and wet, or neovascular, age-related macular degeneration ...

Besides AMD, injections can treat other conditions affecting the light-sensitive retina, such as diabetic retinopathy and retinal vein occlusions (blockages). These injections deliver medication such ...

Napoleone Ferrara, will help accelerate the clinical development of TH103 for neovascular age-related macular degeneration ("nAMD") as well as other diseases such as diabetic macular edema ("DME") and ...